Adapted Medium Chain Triglyceride Compositions for Specialized Environments

Publication ID: 24-11857527_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adapted Medium Chain Triglyceride Compositions for Specialized Environments,” Published Technical Disclosure No. 24-11857527_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857527_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,527.

Summary of the Inventive Concept

The present inventive concept relates to adapted medium chain triglyceride (MCT) compositions specifically designed for high-altitude, disaster relief, extreme weather, high-security, and remote or isolated settings, providing ketones and/or C10 fatty acids to individuals in these unique operational environments.

Background and Problem Solved

The original patent disclosed MCT compositions for treating brain energy deficiency conditions and neurological diseases. However, these compositions may not be suitable for use in specialized environments where specific challenges and requirements exist. The present inventive concept addresses the need for adapted MCT compositions that can effectively provide ketones and/or C10 fatty acids in these niche settings.

Detailed Description of the Inventive Concept

The adapted MCT compositions comprise a blend of MCT-C8 and MCT-C10 in specific ratios tailored to the unique demands of each environment. For high-altitude conditions, the composition comprises a MCT-C8 and a MCT-C10 in a ratio of 30:70 to 70:30 (mol/mol). For disaster relief settings, the composition is easily transportable and has a long shelf life, with a MCT-C8 and a MCT-C10 in a ratio of 40:60 to 60:40 (mol/mol). In extreme weather conditions, the composition further comprises an additive that enhances stability in high-temperature environments, with a MCT-C8 and a MCT-C10 in a ratio of 50:50 to 80:20 (mol/mol). For high-security environments, the composition is tamper-evident and has a secure packaging system, with a MCT-C10 and a MCT-C8 in a ratio of 80:20 to 95:5 (mol/mol). Finally, for remote or isolated settings, the composition can be easily stored and transported, with a MCT-C8 and a MCT-C10 in a ratio of 20:80 to 50:50 (mol/mol).

Novelty and Inventive Step

The present inventive concept is novel and non-obvious over the original patent due to its specific adaptation to unique operational environments, requiring tailored MCT compositions that address the distinct challenges and requirements of each setting.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include varying the ratio of MCT-C8 to MCT-C10, using different types of MCTs, or incorporating additional additives to enhance stability or bioavailability. Variations may also include adapting the composition for use in other specialized environments, such as space exploration or high-stress occupations.

Potential Commercial Applications and Market

The adapted MCT compositions have significant commercial potential in various industries, including sports nutrition, military operations, disaster relief, and healthcare. The target market includes individuals and organizations operating in high-altitude, disaster relief, extreme weather, high-security, and remote or isolated settings, where the provision of ketones and/or C10 fatty acids can be critical for optimal performance and health.

Field of Art

Pharmaceutical and nutritional compositions, specifically medium-chain triglyceride (MCT) formulations for neurological and metabolic applications, requiring expertise in organic chemistry, biochemistry, and pharmaceutical engineering

Person of Ordinary Skill (PHOSITA) Profile

A researcher or formulation scientist with advanced degrees in chemistry or biochemistry, experienced in lipid composition design, familiar with MCT properties, metabolic pathways, and environmental adaptation strategies for pharmaceutical compositions

Obviousness Rationale

A PHOSITA would recognize that adapting MCT compositions for specialized environments represents a predictable variation of the source patent's core technology. The fundamental MCT-C8 and MCT-C10 ratio teachings provide a clear framework for systematic compositional modifications. Environmental adaptations would be considered routine optimization within the established technological domain of MCT formulation.

Obvious Combinations & Variations

Source Patent Element
MCT composition with specific C8 and C10 fatty acid ratios (20:80 to 85:15 mol/mol)
PTD Variation
Tailored MCT ratios for high-altitude, disaster relief, extreme weather, high-security, and remote environments
Obviousness Reasoning
Adjusting MCT ratios within known ranges represents a predictable design choice for targeted metabolic and environmental performance
Source Patent Element
Method of treating brain energy deficiency conditions using MCT compositions
PTD Variation
Specialized delivery systems for MCT compositions in challenging operational environments
Obviousness Reasoning
Adapting pharmaceutical delivery mechanisms for specific contexts is a standard engineering approach with expected outcomes
Source Patent Element
MCT compositions comprising at least 98 mol% MCT-C8 and MCT-C10
PTD Variation
Adding stability-enhancing additives for extreme temperature environments
Obviousness Reasoning
Incorporating stabilizing agents is a known technique for extending pharmaceutical composition performance in challenging conditions
Source Patent Element
Neurological condition treatment using MCT compositions
PTD Variation
Context-specific MCT formulations for high-stress or isolated settings
Obviousness Reasoning
Modifying pharmaceutical compositions for specific use cases represents routine professional skill in formulation design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857527, a person of ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure to be obvious extensions of the prior art. The systematic adaptation of medium-chain triglyceride compositions to specialized environments represents predictable variations within the established technological framework, thereby rendering potential claims obvious under 35 U.S.C. § 103.

Original Patent Information

Patent NumberUS 11,857,527
TitleMedium chain triglyceride compositions
Assignee(s)SOCIÉTÉ DES PRODUITS NESTLÉ S.A.